The global market for synthetic lethality drugs and targets is projected to grow from $1.3 billion in 2023 to over $5.3 billion by 2033, with a CAGR of 15.09%. North America is expected to dominate the market due to advances in genetic science and rising cancer rates, while the Asia-Pacific region is anticipated to experience the fastest growth. Key players include Pfizer, AbbVie, and AstraZeneca, with increasing investments in biotechnology and personalized medicine driving innovation in cancer treatment.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
